Articles

• Assessment of CE-MRA for the rapid detection of supra-aortic vascular disease

  V. L. Wright, W. Olan, B. Dick, H. Yu, N. Alberts-Grill, L. L. Latour, A. E. Baird

  • Abstract
  • Full Text
  • Full Text (PDF)
• Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

  P. Soelberg Sorensen, N. Koch-Henriksen, C. Ross, K. M. Clemmesen, K. Bendtzen, the Danish Multiple Sclerosis Study Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• Neutralizing antibodies and efficacy of interferon β-1aA 4-year controlled study

  L. Kappos, M. Clanet, M. Sandberg-Wollheim, E. W. Radue, H. P. Hartung, R. Hohlfeld, J. Xu, D. Bennett, A. Sandrock, S. Goelz, the European Interferon Beta-1a IM Dose-Comparison Study Investigators

  • Abstract
  • Full Text
  • Full Text (PDF)
• Interferon β-1a in MSResults following development of neutralizing antibodies in PRISMS

  Gordon S. Francis, George P.A. Rice, Jonathan C. Alsop

  • Abstract
  • Full Text
  • Full Text (PDF)
• Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients

  A. Minneboo, B. M. J. Uitdehaag, H. J. Ader, F. Barkhof, C. H. Polman, J. A. Castelijns

  • Abstract
  • Full Text
  • Full Text (PDF)
• Prevalence of depressive disorders and change over time in late-stage ALS

  J. G. Rabkin, S. M. Albert, M. L. Del Bene, I. O'Sullivan, T. Tider, L. P. Rowland, H. Mitsumoto

  • Abstract
  • Full Text
  • Full Text (PDF)
• Wish to die in end-stage ALS

  S. M. Albert, J. G. Rabkin, M. L. Del Bene, T. Tider, I. O'Sullivan, L. P. Rowland, H. Mitsumoto

  • Abstract
  • Full Text
  • Full Text (PDF)
• A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD

  J. L. Chang, C. Lomen-Hoerth, J. Murphy, R. G. Henry, J. H. Kramer, B. L. Miller, M. L. Gorno-Tempini

  • Abstract
  • Full Text
  • Full Text (PDF)
• The impact of lesion side on acute stroke treatment

  Silvia Di Legge, Jiming Fang, Gustavo Saposnik, Vladimir Hachinski

  • Abstract
  • Full Text
  • Full Text (PDF)
• Early-onset parkinsonism associated with PINK1 mutationsFrequency, genotypes, and phenotypes

  V. Bonifati, C. F. Rohé, G. J. Breedveld, E. Fabrizio, M. De Mari, C. Tassorelli, A. Tavella, R. Marconi, D. J. Nicholl, H. F. Chien, E. Fincati, G. Abbruzzese, P. Marini, A. De Gaetano, M. W. Horstink, J. A. Maat-Kievit, C. Sampaio, A. Antonini, F. Stocchi, P. Montagna, V. Toni, M. Guidi, A. Dalla Libera, M. Tinazzi, F. De Pandis, G. Fabbrini, S. Goldwurm, A. de Klein, E. Barbosa, L. Lopiano, E. Martignoni, P. Lamberti, N. Vanacore, G. Meco, B. A. Oostra, The Italian Parkinson Genetics Network

  • Abstract
  • Full Text
  • Full Text (PDF)
• Influence of alcohol on gait in patients with essential tremor

  S. Klebe, H. Stolze, K. Grensing, J. Volkmann, R. Wenzelburger, G. Deuschl

  • Abstract
  • Full Text
  • Full Text (PDF)
• A total score for the CERAD neuropsychological battery

  M. J. Chandler, L. H. Lacritz, L. S. Hynan, H. D. Barnard, G. Allen, M. Deschner, M. F. Weiner, C. M. Cullum

  • Abstract
  • Full Text
  • Full Text (PDF)
• Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age

  D. J. Vinkers, M. L. Stek, R. C. van der Mast, A.J.M. de Craen, S. Le Cessie, J. Jolles, R. G.J. Westendorp, J. Gussekloo

  • Abstract
  • Full Text
  • Full Text (PDF)
• Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles

  V. Lewis, A. F. Hill, G. M. Klug, A. Boyd, C. L. Masters, S. J. Collins

  • Abstract
  • Full Text
  • Full Text (PDF)
• Measuring atrophy in Alzheimer diseaseA serial MRI study over 6 and 12 months

  J. M. Schott, S. L. Price, C. Frost, J. L. Whitwell, M. N. Rossor, N. C. Fox

  • Abstract
  • Full Text
  • Full Text (PDF)